Taddio A, Rossi EDei, Monasta L, Pastore S, Tommasini A, Lepore L, Bronzetti G, Marrani E, Mottolese BD'Agata, Simonini G, Cimaz R, Ventura A. Describing Kawasaki shock syndrome: results from a retrospective study and literature review. Clin Rheumatol 2017;36(1):223-228.

Lucafò M, Bravin V, Tommasini A, Martelossi S, Rabach I, Ventura A, Decorti G, De Iudicibus S. Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance. Clin Exp Pharmacol Physiol 2016;43(6):602-5.

Paloni G, Pastore S, Tommasini A, Lepore L, Taddio A. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy. Clin Exp Rheumatol 2015;33(5):766.

Girardelli M, Arrigo S, Barabino A, Loganes C, Morreale G, Crovella S, Tommasini A, Bianco AMonica. The diagnostic challenge of very early-onset enterocolitis in an infant with XIAP deficiency. BMC Pediatr 2015;15(1):208.

De Pieri C, Taddio A, Insalaco A, Barbi E, Lepore L, Ventura A, Tommasini A. Different presentations of mevalonate kinase deficiency: a case series. Clin Exp Rheumatol 2015;33(3):437-42.

Notarangelo LDaniele, Tommasini A. Defective and excessive immunities in pediatric diseases. Curr Pharm Des 2012;18(35):5729-34.

Piscianz E, Cuzzoni E, De Iudicibus S, Valencic E, Decorti G, Tommasini A. Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. Int Immunopharmacol 2011;11(12):2242-5.

Marcuzzi A, Decorti G, Pontillo A, Ventura A, Tommasini A. Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. Inflamm Res 2010;59(5):335-8.